247 related articles for article (PubMed ID: 34027005)
1. Molecular characterization and antimicrobial susceptibility testing of clinical and non-clinical
Wareth G; El-Diasty M; Abdel-Hamid NH; Holzer K; Hamdy MER; Moustafa S; Shahein MA; Melzer F; Beyer W; Pletz MW; Neubauer H
One Health; 2021 Dec; 13():100255. PubMed ID: 34027005
[TBL] [Abstract][Full Text] [Related]
2. Identification, Genotyping and Antimicrobial Susceptibility Testing of
Khan AU; Shell WS; Melzer F; Sayour AE; Ramadan ES; Elschner MC; Moawad AA; Roesler U; Neubauer H; El-Adawy H
Microorganisms; 2019 Nov; 7(12):. PubMed ID: 31766725
[TBL] [Abstract][Full Text] [Related]
3. Determination of Virulence-Associated Genes and Antimicrobial Resistance Profiles in
Dadar M; Alamian S; Brangsch H; Elbadawy M; Elkharsawi AR; Neubauer H; Wareth G
Pathogens; 2023 Jan; 12(1):. PubMed ID: 36678430
[TBL] [Abstract][Full Text] [Related]
4. [Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures].
Keşli R; Bilgin H; Yılmaz H
Mikrobiyol Bul; 2017 Jul; 51(3):260-268. PubMed ID: 28929962
[TBL] [Abstract][Full Text] [Related]
5. Whole-Genome Sequencing for Tracing the Genetic Diversity of
Khan AU; Melzer F; Sayour AE; Shell WS; Linde J; Abdel-Glil M; El-Soally SAGE; Elschner MC; Sayour HEM; Ramadan ES; Mohamed SA; Hendam A; Ismail RI; Farahat LF; Roesler U; Neubauer H; El-Adawy H
Pathogens; 2021 Jun; 10(6):. PubMed ID: 34208761
[TBL] [Abstract][Full Text] [Related]
6. The canonical Brucella species-host dependency is changing, however, the antibiotic susceptibility profiles remain unchanged.
Celik E; Kayman T; Buyuk F; Gulmez Saglam A; Abay S; Akar M; Karakaya E; Balkan Bozlak CE; Coskun MR; Buyuk E; Celebi O; Sahin M; Saticioglu IB; Durhan S; Baykal A; Ersoy Y; Otlu S; Aydin F
Microb Pathog; 2023 Sep; 182():106261. PubMed ID: 37488036
[TBL] [Abstract][Full Text] [Related]
7. The perspective of antibiotic therapeutic challenges of brucellosis in the Middle East and North African countries: Current situation and therapeutic management.
Wareth G; Dadar M; Ali H; Hamdy MER; Al-Talhy AM; Elkharsawi AR; Tawab AAAE; Neubauer H
Transbound Emerg Dis; 2022 Sep; 69(5):e1253-e1268. PubMed ID: 35244335
[TBL] [Abstract][Full Text] [Related]
8. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization and antimicrobial susceptibility of human
Ma HR; Xu HJ; Wang X; Bu ZY; Yao T; Zheng ZR; Sun Y; Ji X; Liu J
Front Microbiol; 2023; 14():1137932. PubMed ID: 37125183
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance.
Abdel-Maksoud M; House B; Wasfy M; Abdel-Rahman B; Pimentel G; Roushdy G; Dueger E
Ann Clin Microbiol Antimicrob; 2012 Aug; 11():24. PubMed ID: 22929054
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran.
Razzaghi R; Rastegar R; Momen-Heravi M; Erami M; Nazeri M
Indian J Med Microbiol; 2016; 34(3):342-5. PubMed ID: 27514957
[TBL] [Abstract][Full Text] [Related]
12. Proteomics-based screening and antibiotic resistance assessment of clinical and sub-clinical Brucella species: An evolution of brucellosis infection control.
Elbehiry A; Aldubaib M; Al Rugaie O; Marzouk E; Abaalkhail M; Moussa I; El-Husseiny MH; Abalkhail A; Rawway M
PLoS One; 2022; 17(1):e0262551. PubMed ID: 35025975
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey.
Ilhan Z; Solmaz H; Ekin IH
J Vet Med Sci; 2013; 75(8):1035-40. PubMed ID: 23545462
[TBL] [Abstract][Full Text] [Related]
14. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
Deshmukh A; Hagen F; Sharabasi OA; Abraham M; Wilson G; Doiphode S; Maslamani MA; Meis JF
BMC Microbiol; 2015 Jun; 15():121. PubMed ID: 26073177
[TBL] [Abstract][Full Text] [Related]
15. Identification and determination of antibiotic susceptibilities of Brucella strains isolated from patients in van, Turkey by conventional and molecular methods.
Parlak M; Güdücüoğlu H; Bayram Y; Çıkman A; Aypak C; Kılıç S; Berktaş M
Int J Med Sci; 2013; 10(10):1406-11. PubMed ID: 23983603
[TBL] [Abstract][Full Text] [Related]
16. In vitro antimicrobial susceptibility of Brucella species.
Baykam N; Esener H; Ergönül O; Eren S; Celikbas AK; Dokuzoguz B
Int J Antimicrob Agents; 2004 Apr; 23(4):405-7. PubMed ID: 15081093
[TBL] [Abstract][Full Text] [Related]
17. Species-specific PCR for the Diagnosis and Determination of Antibiotic Susceptibilities of
Irajian GR; Masjedian Jazi F; Mirnejad R; Piranfar V; Zahraei Salehi T; Amir Mozafari N; Ghaznavi-Rad E; Khormali M
Iran J Pathol; 2016; 11(3):238-247. PubMed ID: 27799972
[TBL] [Abstract][Full Text] [Related]
18. Detection of Virulence-Associated Genes among
Papaparaskevas J; Procopiou A; Routsias J; Vrioni G; Tsakris A
Pathogens; 2023 Oct; 12(11):. PubMed ID: 38003739
[TBL] [Abstract][Full Text] [Related]
19. Reduced Susceptibility to Rifampicin and Resistance to Multiple Antimicrobial Agents among Brucella abortus Isolates from Cattle in Brazil.
Barbosa Pauletti R; Reinato Stynen AP; Pinto da Silva Mol J; Seles Dorneles EM; Alves TM; de Sousa Moura Souto M; Minharro S; Heinemann MB; Lage AP
PLoS One; 2015; 10(7):e0132532. PubMed ID: 26181775
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of
Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
